Introduction
Half-sandwich complexes of ruthenium, osmium, rhodium and iridium are a versatile class of organometallic compounds. Their accessibility, robustness, air-stability and water- 20 solubility are examples of the unique properties that allow their applications in various fields of chemistry such as in synthesis and catalysis, 1 or as building blocks in supramolecular chemistry.
2 Their biological behaviour as anticancer drugs is also highly promising.
3 During the last 10 25 years, half-sandwich arene and cyclopentadienyl complexes 4 of Ru II , 5 Os II , 6 Rh III , 7 and Ir III , 8 for example, have all shown promise as antitumoural and/or antimetastatic candidates, and structure-activity relationships guiding new design concepts have begun to emerge. Clusters containing boron and carbon, termed carbaboranes, are a class of compounds that possess different sizes, architectures, charges and dipole moments. 10 Among them, icosahedral dicarba-closo-dodecarboranes (C 2 B 10 H 12 ) were 35 first reported in 1963.
11 Three isomers, 1,2-1,7-and 1,12-dicarba-closo-dodecarboranes (or ortho, meta and paradicarba-closo-dodecarboranes), exist depending on the positions of the two carbon atoms. The molecular geometry of o, m and p-dicarba-closo-dodecarboranes with the IUPAC 40 numbering of the cage atoms 12 are shown together in Figure 1 .
The carbon and boron atoms in these polyhedral clusters are hypercoordinated (hexacoordinated) which leads to the formation of 20 triangular faces. 13 The hexacoordination of Figure 1 . Molecular geometry of o, m and p-dicarba-closododecarboranes. 12 Beyond these non-classical bonding interactions, dicarbacloso-dodecarboranes possess unusual properties, including 70 high symmetry and remarkable stability; these properties have given rise to numerous applications. For example, dicarbacloso-dodecarborane compounds have been used as building blocks in various systems, such as dendrimers, 16 polymers, 17 and nanoparticles. 18 The weakly acidic character of the CH 75 groups of these clusters of boron and carbon allows their chemical functionalization. 19 Thus, various molecules containing dicarba-closo-dodecarboranes along with analogues of biomolecules have been reported and have found biochemical applications.
of application of dicarba-closo-dodecarborane molecules in medicine. This binary method consists of the nuclear reaction of nontoxic and nonradioactive 10 B atoms and low-energy thermal neutrons that produces high-energy 4 He 2+ α-particles and 7 Li 3+ ions. The dissipation of the high kinetic energy of 25 these particles is achieved in a small distance (less than one cell diameter), which allows accurate destruction of the targeted cells. Therefore, the efficiency of this therapy depends on the number of boron atoms delivered to cancer cells, while the selectivity strongly depends on the 30 preferential accumulation of boron in tumour tissues rather than in normal tissues, as well as on the low general cytotoxicity of the compounds. 25 Dicarba-closododecarboranes contain ten boron atoms; they possess a rather low cytotoxicity and these clusters are extremely stable in 35 biological medium. These characteristics explain why dicarbacloso-dodecarborane clusters have the potential to be efficient BNCT agents. However, dicarba-closo-dodecarborane clusters on their own do not possess the ability to selectively target cancer cells. 40 To increase the selectivity of dicarba-closo-dodecarboranes towards cancer cells and therefore to increase the clinical feasibility of boron neutron capture therapy, various approaches have been developed. A first strategy to obtain 45 selectivity towards cancer cells is to attach borane clusters to cellular building blocks. Indeed, most solid tumours are known to possess a hypervasculature, a defective vascular architecture, and an impaired lymphatic drainage. 26 Thus, while the normal endothelial layer surrounding the blood 50 vessels feeding healthy cells restricts the amount of constituents necessary for cell replication (amino acids and nucleic acid precursors for example), the endothelial layer of blood vessels in diseased tissues allows an elevated quantity of such cell constituents to enter the cells. 23 , 27 Another 55 strategy is to attach the borane cluster to tumour antibodies that can target specific cell types. 28 A third approach is to use nano-containers such as lipoproteines and liposomes. 29 Encapsulation of hydrophilic borane compounds in aqueous cores of liposomes, or incorporation of boron-containing 60 lipids in liposome bilayers leads to a selective delivery of BNCT therapeutics to tumours.
On the other hand, mononuclear arene ruthenium complexes are known to target DNA and RNA 30 but they are also able to 65 bind biomolecules such as the sulphur-containing amino acids L-cysteine and L-methionine 31 and imidazole-containing amino acid L-histidine, 32 for example. Thus, the attachment of dicarba-closo-dodecarborane clusters to arene ruthenium halfsandwich complexes able to bind cellular building blocks 70 could result in an increase of the selectivity of dicarba-closododecarboranes towards cancer cells. Moreover, the synthetic diversity of the arene ligand provides an excellent scaffold for the coupling of organic segments for targeted chemotherapy. 33 The selectivity for cancer cells of arene ruthenium complexes 75 has been shown to be dependent on ligands surrounding the metal centre. For example, the water-soluble phosphine ligand 1,3,5-triaza-7-phospha-tricyclo-[3.3.1.1]decane (pta) seems to play a significant role in the selectivity of the RAPTA-C [pcymRu(pta)Cl 2 ] (p-cym = para-cymene) complex. 34 80 Therefore, the combination of nontoxic, highly stable and high-boron content dicarba-closo-dodecarborane molecules with low toxic biomolecule-containing complexes could result in the synthesis of BNCT agents possessing a high selectivity for cancer cells. The medicinal chemistry of dicarba-closo-dodecarboranes 90 covers a much broader field than the niche of boron neutron capture therapy. 21, 25, 28 The unique properties of these molecules have found application in radionuclide diagnostics, for example. Indeed, due to the high stability of dicarba-closododecarboranes under in vivo conditions, the labelling of these 95 clusters by radionuclides affords compounds that resist degradation better than conventional organic molecules. 28 The labelling of dicarba-closo-dodecarborane derivatives with radioactive isotopes such as 99 Tc, 57 Co and 73 Se allows the determination of compound distribution by various 100 techniques, including positron emission tomography (PET) and magnetic resonance imaging (MRI). These imaging techniques, currently under investigation, 35 could be applied to the study of the mechanisms of action of half-sandwich complexes. Utilisation in radionuclide therapy of such 105 complexes could also be considered after functionalization of the arene unit with antibodies to enhance the selective delivery of radionuclides into cancer cells, for example. Another potential interest in the combination of dicarba-closododecarboranes and half-sandwich complexes of ruthenium, 110 osmium, rhodium and iridium for biological applications lies in the spherical geometry, the steric hindrance and the very strong hydrophobic character of dicarba-closododecarboranes: 36 Indeed, a dicarba-closo-dodecarborane molecule has a diameter of about 1 nm and a volume approximately 40% larger than the volume of a rotating phenyl group. 14 The degree of potential functionalization of dicarba-closo-dodecarboranes being much higher than that of 5 phenyl rings, dicarba-closo-dodecarboranes are considered as convincing bioisosteres for aryl, cycloalkyl or adamantyl units. For instance, this approach has been used by Valliant and co-workers to synthesise an analogue compound of tamoxifen in-which the A phenyl group has been substituted 10 by an o-dicarba-closo-dodecarborane unit. 37 On the other hand, the hydrophobic arene and cyclopentadienyl ligands and the hydrophilic metal centres give amphiphilic properties to the arene/cyclopentadienyl 15 metal units. This amphiphilic behaviour has been one of the major reasons to the development of arene-ruthenium-based anticancer drugs.
3e Therefore, the utilisation of dicarba-closododecarboranes as ligands presenting both steric and hydrophobic unusual effects could increase the bioavailability 20 and the cytotoxicity of half-sandwich complexes of ruthenium, osmium, rhodium and iridium.
1.C. To provide half-sandwich complexes with useful dicarba-closo-dodecarborane spectroscopic probes. Dicarba-closo-dodecarboranes introduce useful and characteristic probe properties that can be utilised not only for 30 the characterisation of the complexes incorporating boron cluster ligands but also for the determination of interactions between these and biomolecules.
The Raman and IR spectra of the three dicarba-closo-35 dodecarborane isomers are very similar, (see Figure 2 for the corresponding spectra of solid p-dicarba-closododecarborane). The infrared spectra of these boron clusters contain a strong and broad absorption band at around 2600 cm -1 due to B−H stretching vibrations. Along with this 40 absorption, an intense Raman line is also observed in the region of 760 cm -1 . 38 The fact that some bands are active only in Raman spectroscopy and some others only in IR spectroscopy implies that both IR and Raman spectra should be measured to collect the full information given by 45 vibrational spectroscopy. 
60
The very characteristic Raman stretching signal of B-H at around 2600 cm -1 allows the utilisation of dicarba-closododecarboranes as Raman reporters and biological probes. Indeed, this signal is in a spectroscopically silent region of 65 cells. This vibrational property has been recently used by Pezacki and co-workers in studies of the functionalization of silver nanoparticles by 1-thiol-o-dicarba-closo-dodecarborane, followed by functionalization with an antibody. 39 Combination of dicarba-closo-dodecarboranes with surfaces 70 and nanoparticles can lead to compounds presenting enhanced Raman properties, 40 while the functionalization with antibodies provides a strong selectivity for targeted cancer cells.
Surface-Enhanced Raman Scattering (SERS) microscopy has been used to demonstrate tumour cell 75 targeting of this nanostructure as well as the delivery of a high concentration of boron atoms into targeted cancer cells. Figure 4a . Figure 4b illustrates Figure 4c . 
40
Mass spectrometry is a method of choice for the identification of the isotopic compositions of carbaboranes. Indeed, the characteristic isotopic patterns of the two isotopes 11 B and 10 B can be used to obtain indirect information on the nido (B 9 ) or closo (B 10 ) structure of the cluster. The combination of dicarba-closo-dodecarboranes with halfsandwich complexes of ruthenium, osmium, rhodium and iridium can provide a distinct isotopic pattern depending on 80 the nature of the metal centre.
1.D.
To target specific proteins.
1.D.1. Estrogen and retinoid receptors.

85
Dicarba-closo-dodecarboranes and dicarba-closododecarborane derivatives have been used as pharmacophores to enhance the hydrophobic interactions of pharmaceutical compounds with estrogen 42 and retinoid receptors. 43 The 90 estrogen receptor (ER) agonist behaviour of these dicarbacloso-dodecarborane derivatives is of central importance. 44 Indeed, in ER positive tumours, such as in some breast cancers, the estrogen receptors are over-expressed which cause a cell proliferation and in fine an increase of the tumour 95 size. In the meantime, an ER deficiency leads to a loss of bone mass due to the estrogenic regulation of bone maintenance. 23 Thus many efforts are focused on the synthesis of ER agonists and antagonists.
100
The X-ray structure of the human ligand binding domain (LBD) hERαLBD of the estrogen receptor has been determined. 45 LBD contains a phenolic unit, a hydrophobic cavity and a polar group such as an amine or alcohol. A molecule able to bind this domain should therefore present 105 matching characteristics. Precisely, the phenolic 17β-estradiol, which is the endogenous ligand for estrogen receptor, bears a phenolic residue, an hydrophobic group adjacent to the phenolic ring, and another hydroxyl group located at a suitable position on the molecule, (see Figure 6a ). 110 Based on these considerations, in 1999 Endo and co-workers biologically evaluated compounds having phenolic ring, mdicarba-closo-dodecarborane or p-dicarba-closododecarborane as a hydrophobic moiety with a hydrophilic group on the dicarba-closo-dodecarborane cluster (alcohol, 115 amine or carboxylic acid), (see Figure 6b for an example of such molecules). These types of compounds are efficient ER agonists. for the design of a library of potential ER binding ligands incorporating dicarba-closo-dodecarboranes. 23, 47 Docking simulations have also been performed 48 as well as in vivo experiments that demonstrate that the administration of such compounds to estrogen-deficient mice prevents bone loss as 25 effectively as administration of 17β-estradiol. 23 Retinoic acid is a natural metabolite of vitamin A that is involved in the regulating the development of normal and tumoral epithelial cells in various tissues. 49 The utilisation of 30 retinoic acid as a clinical drug for the treatment of acute promyelocytic leukemia has been recently approved. 50 Retinoids are related compounds of retinoic acid able to bind and to activate specific nuclear retinoic acid receptors (RARs) 51 and retinoid X receptors (RXRs) 52 receptors. The 35 resulting complexes act then as modulators for the target gene transcription. 53 The affinity between these ligands and their receptors is due to precise structural features, 51, 54 such as the presence of a carboxylic acid group linked to a hydrophobic pharmacophore by an appropriate spacer. 46 40 In this context and following the same strategy developed for the estrogen receptor agonists, Endo and co-workers synthesised RARs and RXRs agonists containing the high hydrophobic dicarba-closo-dodecarborane units. 53 The 45 structure-activity relationship demonstrated that for a same compound the bulky dicarba-closo-dodecarborane unit fits better the RAR cavity than the RXR cavity. This interesting difference of selectivity between dicarba-closododecarboranes and RAR/RXR binding domains has been 50 explained by docking simulations performed by Calvaresi and Zerbetto. 55 Indeed, for one of the two sites of interaction of dicarba-closo-dodecarborane with these LBDs, the dicarbacloso-dodecarborane unit matches the C 12 region of RARs, while the C=C double bond region is targeted for RXRs, (see The experimental results of Endo along with the simulations of Calvaresi and Zerbetto suggest that dicarba-closododecarborane derivatives could be used in the development of selective agonists or antagonists of RARs and RXRs. 
1.D.2. Kinases and proteases.
The human genome encodes 518 kinases. The active sites of these kinases possess similar structures and sequences but the regulation of their catalytic activity differs. On the other hand, 90 perturbations of protein kinase-mediated cell signalling pathways are observed in cancers, diabetes and inflammations. 56 Thus, modulation of kinase activity is of major importance. 95 Interest in using dicarba-closo-dodecarboranes as pharmacophore to target kinases was pioneered in 1999 by Endo and co-workers, with the synthesis of benzolactam molecules bearing dicarba-closo-dodecarborane units and acting as protein kinase C modulators. 57 These compounds 100 mimic the active conformation and structure of teleocidins that are potent tumour promoters able to activate protein kinase C, 58 and induce growth inhibition and cell adhesion. 59 The high activity found for these dicarba-closododecarborane-containing benzolactams indicate that they 105 possess the requisite structures for hydrogen-bonding and hydrophobic interaction with protein kinase C. Docking simulations were also performed and matching structures between ligands and protein kinase C CRD2 domain were found. The strong hydrophobic pharmacophore behaviour of dicarba-closo-dodecarboranes, 15 the regioselectivity and ease of derivatisation of these molecules and their chemical stability and metabolic inertness make them attractive candidates for the inhibition of proteases. In particular some dicarba-closo-dodecarborane derivatives are currently in advanced stages of development as 20 inhibitors of HIV protease. 61 The in silico recognition and binding of a basic residue inside a hydrophobic pocket (S 1 ) of the serine protease MBL-associated serine protease-2 (MASP-2) illustrates the ability of dicarba-closo-dodecarboranes to specifically bind some residues of proteases. 55 The docked 25 complex of dicarba-closo-dodecarborane and MASP-2 is shown in Figure 8 . 
1.E. To design anticancer drugs.
The combination of the demonstrated biological properties of 60 half-sandwich complexes of ruthenium, osmium, rhodium and iridium [3] [4] [5] [6] [7] [8] with the characteristics of dicarba-closododecarboranes provides a promising basis for the design of new efficient anticancer agents. For example, confocal fluorescence microscopic studies have been performed with the 65 ferrocene-containing ruthenium complex [pcymRu(S 2 C 2 (B 10 H 9 )(H 2 CCFc))] (see Figure 9 for the molecular structure of complex [p-cymRu(S 2 C 2 (B 10 H 9 )(H 2 CCFc))]) in order to evaluate the effect of this complex on the uptake of the fluorescent daunorubicin drug into cancer cells (see Figure 10C   70 for the molecular structure of daunorubicin). 
62
A weak fluorescence was observed when drug-resistant K562/ADM leukemia cells were incubated with daunorubicin alone. Moreover, this fluorescence was concentrated in the cell membranes, (see Figure 10A and 10a) . However, when 90 K562/ADM cells were incubated with a mixture of daunorubicin and non-fluorescent complex [p-cymRu(S 2 C 2 (B 10 H 9 )(H 2 CCFc))] a strong fluorescence was observed indicating significant uptake of daunorubicin into the cells, (see Figure 10B and 10b) . Figure  10D summarises these data with a superposition of the relative 95 fluorescence intensity curves of 10a and 10b. Yan and co-workers have also studied the cytotoxicity of complex [p-cymRu(S 2 C 2 (B 10 H 9 )(H 2 CC(CO 2 H)))], (see Figure  11 for the molecular structure of complex [p-20 cymRu(S 2 C 2 (B 10 H 9 )(H 2 CC(CO 2 H)))]). 63 The (5), and [p-cymOs(S 2 C 2 (B 10 H 10 ))] (6), respectively (see Figure 12 for the synthesis of 1 6). Complexes 1 6 contain an almost planar pseudo-aromatic metalla-cycle MEC 2 (M = Ir, Rh, Ru, Os and E = Se, S). The steric hindrance due to the bulky o-dicarba-closo- 105 dodecarborane-1,2-dichalcogenolate ligands prevents the dimerisation of these 16-electron complexes and formation of more stable 18-electron adducts. 68 Therefore, the monomerdimer equilibrium reported for different dichalcogene 16-electron half-sandwich complexes 69 is not observed in these 110 cases. The air-stable 16-electron complexes are particularly interesting as synthetic precursors since addition reactions can be carried out directly on the metal centre or insertion reactions and B-H activation.
2.A.2. Addition reactions on the metal centre.
Numerous examples of addition reactions on the metal centre 5 of complexes 1 6 have been reported: Herberhold and coworkers described the syntheses of coordinatively saturated 18-electron adducts obtained from precursors 1 6 and Lewis bases. 64 -67 X-ray structure analyses show that the metallacycle MEC 2 is bent and that the pseudo-aromaticity is 10 partially or totally lost upon addition reactions. This decrease of the symmetry order (C 2v > C s ) was studied with complex 1 by addition of PMe 3 , the resulting complex being [Cp*Ir(Se 2 C 2 (B 10 H 10 ))(PMe 3 )] (7). 64 An increase of 10 pm for the bond length Ir-Se (2.37 to 2.47 Å) in the solid state and a 15 decrease of the Se-Ir-Se angle from 93.6° to 90.2° occurs for complex 7, while the C 1 -C 2 bond length increases from 1.61 to 1.65 Å, suggesting a loss of the pseudo-aromaticity of the MEC 2 metalla-cycle, (see Figure 13 ). Following the same strategy as for addition reactions, different electron donor molecules such as NH 3 , CO, NC 5 H 5 , CN -, SCN -, SEt 2 and P(OMe) 3 have been used to convert 16-electron complexes 1 6 into their 18-electron congeners. 40 The importance of the ligating atom of the Lewis base was established for complex 5 and with a decreasing stability order C > P > N > S > O.
67
Addition reactions on the metal centres of complexes 1 6 45 can be used to synthesise multinuclear complexes. 70 Reactions between these 16-electron complexes and pyridinyl-based linear bidentate ligands such as pyrazine, 71 4,4'-bipyridine, 
2.A.3. Direct formation of metal-metal bonds.
Half-sandwich clusters of ruthenium, osmium, rhodium and iridium are useful and versatile molecules and find 90 applications in various areas. 74 In particular, their potential as catalysts 75 or anticancer agents 76 has been explored. Hence, the rational design of direct metal-metal bond is a subject of major importance. In this context, the electronic deficiency of the metal centre in 16-electron complexes 1 6 leads to a 95 remarkable synthetic ability for the formation of multimetallic complexes by creation of direct metal-metal (M M') bonds.
Different strategies can be employed to synthesise homo-and hetero-binuclear clusters containing half-sandwich complexes 100 and ancillary o-dicarba-closo-dodecarborane-1,2-dichalcogenolate ligands. First, homo-binuclear complexes can be obtained as by-products from the synthesis of the 16-electron precursors 1 6 but this strategy leads to poor yields. For example, the synthesis of complex [Cp* 2 Ir 2 (S 2 C 2 B 10 H 10 )] Routes for the syntheses of homo-and hetero-multinuclear 100 clusters from half-sandwich complexes and ancillary 1,2-dichalcogenolate dicarba-closo-dodecarborane ligands have been described. Concerning the behaviour of these clusters, the combination of the properties of the cyclopentadienyl and arene ligands with the characteristics of the dicarba-closo-dodecarborane units allows control of the solubility of the resulting 30 molecules as well as of their polarity, chirality, redox properties and reactivity. 80 Moreover, the possibility to synthesise homo-or hetero-multinuclear clusters gives a large spectrum of readily accessible molecules with various structures and bonding situations. For example, important 35 variations of the M M' bond length are observed depending on the ligands that surround the different metal centres or depending on the geometry of the cluster. 82 This structural versatility is illustrated by the conversion of (15) reported by Jin and coworkers. 83 In cluster 14, a length of 2.7097(11) Å was found for the Ir 1 Rh bond, while in the isomer 15, the Ir 1 Rh bond length is 3.074(3) Å, (see Figure 15 ). 85 The nature of the ligands also has a crucial influence on the structures of the clusters. The role played by ligands is clearly illustrated in the complex [CpRh(Cp*Rh)(S 2 C 2 (B 10 H 10 ))] (16). Indeed, in the solid state, the metal-sulphur bond in Cp*Rh-S 90 is slightly longer than in CpRh-S (2.3344(11) Å versus 2.3256(11) Å), (see Figure 16) . 79 This structural difference has been attributed to the higher electron density of the Cp* ligand as compared to Cp. dodecarborane-containing half-sandwich complexes of ruthenium, osmium, rhodium and iridium. Herberhold and coworkers reported in 1999 reactions between precursor 4 and acetylene methyl carboxylate and acetylene dimethyldicarboxylate. 84 The formation of a stable 16-electron complex (17) 85 Hydride transfers from boron to rhodium and then from rhodium to the olefinic carbon atom followed by the cleavage of the boron−metal bond lead to the substitution of 40 the dicarba-closo-dodecarborane cluster in positions B(3) and B(6). Thus the reactivity of the metal centre, the metalsulphur bond and the B(3,6)−H bond are involved in the reactions between precursor 4 and unsaturated substrates. Analogous reactions between acetylene methyl carboxylate 45 and precursors 2, 5 and 6 also provide evidence for B−H activation. 86 Compounds 19, 20 and 21 have been obtained with a cisoid geometry for complex 21 and a transoid geometry for complexes 19 and 20. The B−C(1) bond and the η 2 -(S)CH=CH bond are oriented in the same direction in the 50 coordination sphere of the metal centre in a cisoid geometry and in the opposite direction in a transoid geometry, (see Scheme 5) . These compounds are stable and do not undergo further rearrangements. Therefore, the B(3,6)-substitution of the o-dicarba-closo-dodecarborane cluster is not observed 55 with the iridium, ruthenium and osmium analogues of rhodium precursor 4. 
90
This synthetic strategy has been applied to various acetylene derivatives. For instance, the reaction between precursor 1 and phenylacetylene leads to the synthesis of the cisoid 18-electron complex 22, (see Figure 17 ). (26), respectively.
62
The molecular structure of complex 25 is shown in Figure 9 .
The same research group studied recently the reactivity of the 16-electron precursor 5 towards a series of diynes.
69
Interestingly, most of these reactions led to the isolation of 5 mononuclear complexes containing a stable Ru−B bond. Only a binuclear complex was isolated during the reaction of 5 with 2,5-diethynylthiophene. With the other diynes (1,4-diethynylbenzene, 3',6-diethynyl-1,1'-binaphthyl-2,7'-diyl diacetate and 2-bromo-5-ethynylthiophene) the reactivity of 10 the second alkynyl group is inhibited. Electronic rather than steric effects play a key role in the generation of such binuclear complexes. Whilst the sulphur and selenium o-dicarba-closododecarborane-1,2-dichalcogenolate molecules are coordinated to the metal atoms in the vast majority of the 5 reported dicarba-closo-dodecarborane-containing halfsandwich complexes of ruthenium, osmium, rhodium and iridium, a few examples of other dicarba-closo-dodecarborane derivatives employed as ligands can be found in the literature. Among them, the cases of the C,C'-bis(ethynyl)-p-dicarba- 10 closo-dodecarboranes are noteworthy. In 2008, Low and coworkers studied reactions between the cyclopentadienyl ruthenium complex [Cp*Ru(dppe)Cl] (dppe = 1,2-bis(diphenylphosphino)ethane) and two para-dicarba-closododecarborane molecules functionalised on C-H vertices: 1- 15 Me 3 SiC C-1,12-C 2 B 10 H 11 (39) , and 1,12-(Me 3 SiC C) 2 -1,12-C 2 B 10 H 10 (40), (see Figure 19) . 91 These ligands combine the physical and electronic properties of the p-dicarba-closododecarborane units with one or two ethynyl groups. The degree of electronic communication between the axial 20 substituents of the dicarba-closo-dodecarborane cage 40 can be compared to the electronic communication between axial substituents of para-substituted benzenes. 97 Based on different examples, they showed that the coupling reaction of the Cp ring with the dicarbacloso-dodecarborane derivative requires the absence of a substituent on one of the carbon atoms of the cyclopentadienyl 65 unit. Moreover, the presence of a triphenylphosphine coordinated to the metal atom is essential, which indicates a mechanism based on sterically-induced coupling.
Jin and co-workers also extensively used the functionalization 70 of o-dicarba-closo-dodecarborane ligands to synthesise new dicarba-closo-dodecarborane-containing half-sandwich complexes. As an example, in 2005, they synthesised an halfsandwich picolyl-functionalized ortho-dicarba-closododecarborane-containing complex of iridium. 98 The iridium In 2010, the same group published the syntheses of neutral P,S-substituted o-dicarba-closo-dodecarborane-containing 105 half-sandwich complexes of rhodium and iridium. 99 The reaction between [Cp*MCl 2 ] 2 (M = Ir, Rh) and two equivalents of the functionalised o-dicarba-closododecarborane 1-PPh 2 -2-LiS-1,2-C 2 B 10 H 10 gives the neutral P,S-chelated metal complexes [Cp*M(Cl)(1-PPh 2 -2-S-1,2-110 C 2 B 10 H 10 )] (M = Ir (48), Rh (49)), (see Figure 22 for the molecular structure of complex 48). 
Conclusions
It is clear that dicarba-closo-dodecarborane derivatives can give rise to interesting and unusual properties as ligands in 60 organometallic complexes. These clusters are remarkably stable in biological medium and can be recognised by various bio-targets. They can be easily functionalised via organic reactions on the CH vertices and they have useful probe properties. Due to the high number of boron atoms in their 65 globular structures, they have been extensively studied as potential BNCT agents. Different clinical trials have been carried out in Japan, Europe, and the United States and sodium borocaptate (Na 2 B 12 H 11 SH) has been used clinically. Nevertheless, selective and effective delivery of boron agents 70 is still a critical issue. For this reason it is of central importance to explore new concepts able to take advantage of these unique pharmacophores. The combination of dicarbacloso-dodecarboranes with half-sandwich complexes of ruthenium, osmium, rhodium and iridium could provide the 75 expected breakthrough in the dicarba-closo-dodecarborane biochemistry. The synthetic pathways described in this review illustrate the numerous strategies that can be employed to design dicarba-closo-dodecarborane-containing half-sandwich complexes. Addition reactions on the metal centre, B−H 80 activation, transmetalation or functionalization of the cluster cages are some examples of such strategies. The properties of these dicarba-closo-dodecarborane-containing complexes have already allowed their utilisation in organometallic synthesis and biology. However this field of research is relatively recent 85 and new developments and diversification can be expected in the near future. 
